|
Draft Guidelines for the Clinical Translation
of Stem Cells
Draft Guidelines for Comment
The ISSCR has released a draft of the Guidelines for the Clinical Translation of Stem Cells for public comment. The ISSCR Task Force on the Clinical Translation of Stem Cells created the guidelines to define the scientific, clinical, regulatory, ethical and societal issues that must be addressed to ensure that basic stem cell research is responsibly transitioned into appropriate clinical applications for treating patients. To read more, click here.
The period of open public comment ended on October 1, 2008. Thank you to everyone who provided comments; the Task Force is now deliberating on the information received and developing a final document. Download the pdf draft of the Guidelines for public comment by clicking here.
The ISSCR will not comment on the guidelines at this time. This release is for the express purpose of soliciting public comment. The guidelines are still in draft form and the final guidelines will be released at a later date after comments have been received and appropriate revisions have been made to the document.
Task Force Members
The ISSCR has convened a multi-national task force to draft international guidelines for the clinical translation of stem cells and their direct derivatives. Click here to view the roster of task force members.
Funding
The work being undertaken by the ISSCR Task Force on the Clinical Translation of Stem Cells is made possible thanks to the partial support of the EUROCORES Programme EuroSTELLS, a European Science Foundation (ESF) initiative, supported by the European Commission, Sixth Framework Programme, under contract no. ERAS-CT-2003-980409. Research funding is provided by participating national organizations. EuroSTELLS is managed by the European Medical Research Councils (EMRC) at the ESF. The ISSCR also thanks the Alzheimer’s Research Foundation, The Ellison Medical Foundation, and the Juvenile Diabetes Research Foundation Beta Cell Replacement Advisory Committee for their generous financial support of the Task Force.
Updated
October 3, 2008
|
